SEC FORM 4

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khayal Tamer I

(Last)

(First)

(Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER

01810

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/01/2024		M⁽¹⁾		1,458	A	$38.46	22,301	D
Common Stock	10/01/2024		M⁽¹⁾		417	A	$66.1	22,718	D
Common Stock	10/01/2024		M⁽¹⁾		1,083	A	$13.28	23,801	D
Common Stock	10/01/2024		S⁽¹⁾		823	D	$146.15⁽²⁾	22,978	D
Common Stock	10/01/2024		S⁽¹⁾		900	D	$146.9⁽³⁾	22,078	D
Common Stock	10/01/2024		S⁽¹⁾		80	D	$147.98	21,998	D
Common Stock	10/01/2024		S⁽¹⁾		523	D	$149.59⁽⁴⁾	21,475	D
Common Stock	10/01/2024		S⁽¹⁾		318	D	$150.38⁽⁵⁾	21,157	D
Common Stock	10/01/2024		S⁽¹⁾		80	D	$151.2	21,077	D
Common Stock	10/01/2024		S⁽¹⁾		80	D	$152.28	20,997	D
Common Stock	10/01/2024		S⁽¹⁾		20	D	$153.75	20,977	D
Common Stock	10/01/2024		S⁽¹⁾		134	D	$154.86⁽⁶⁾	20,843	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$38.46	10/01/2024		M⁽¹⁾			1,458	⁽⁷⁾	02/24/2031	Common Stock	1,458	$0.00	7,292	D
Stock Option (Right to Buy)	$66.1	10/01/2024		M⁽¹⁾			417	⁽⁸⁾	02/20/2033	Common Stock	417	$0.00	12,098	D
Stock Option (Right to Buy)	$13.28	10/01/2024		M⁽¹⁾			1,083	⁽⁹⁾	02/22/2032	Common Stock	1,083	$0.00	18,417	D

Explanation of Responses:

1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $145.54 to $146.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

3. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $146.555 to $147.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.06 to $150.005, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

5. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.07 to $150.555, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

6. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $154.785 to $154.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

7. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.

8. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027.

9. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

	By: /s/ Stephen Gordon, Attorney-in-Fact	10/03/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Chief Commercial Officer Khayal Tamer I exercised 2,958 shares at a strike of $33.14 and sold $438,491 worth of shares (2,958 units at $148.24) (SEC Form 4)